Functional and molecular effects of imidazoline receptor activation in heart failure

Life Sciences

Volumn 88, Issue 11-12, 2011, Pages 493-503

  Stabile, Angelita Maria ^a,b,d   Aceros, Henry ^a,b   Stockmeyer, Kim ^a   Abdel Rahman, Abdel A ^c   Noiseux, Nicolas ^a,b   Mukaddam Daher, Suhayla ^a,b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c EAST CAROLINA UNIVERSITY   (United States)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Apoptosis; Cardiomyopathy; Echocardiography; Fibrosis; Hamster; Moxonidine

Indexed keywords

COLLAGEN; IMIDAZOLINE RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MOXONIDINE; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; HAMSTER; HEART ANEURYSM; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE FIBROSIS; HEART PERFORMANCE; HEART RATE; HEMODYNAMICS; HISTOLOGY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; TREATMENT DURATION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; COLLAGEN; CRICETINAE; CYTOKINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY; FIBROSIS; HEART FAILURE; HEMODYNAMICS; IMIDAZOLES; IMIDAZOLINE RECEPTORS; MALE; MYOCARDIUM;

CRICETINAE;

EID: 79952454033     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2011.01.008     Document Type: Article

References (45)

1. K. Amann, D. Greber, H. Gharehbaghi, G. Wiest, B. Lange, and U. Ganten Effects of nifedipine and moxonidine on cardiac structure in spontaneously hypertensive rats. Stereological studies on myocytes, capillaries, arteries, and cardiac interstitium Am J Hypertension 5 1992 76 83
2. P. Aukrust, T. Ueland, E. Lien, K. Bendtzen, F. Müller, and A.K. Andreassen Cytokine network in congestive heart failure secondary to ischemic of idiopathic dilated cardiomyopathy Am J Cardiol 83 1999 376 382 (Pubitemid 29066497)
3. E. Bajusz Hereditary cardiomyopathy: a new disease model Am Heart J 77 1969 686 696
4. M.R. Bristow Tumor necrosis factor-alpha and cardiomyopathy Circulation 97 1998 1340 1341
5. M.D. Cheitlin, W.F. Armstrong, G.P. Aurigemma, G.A. Beller, F.Z. Bierman, and J.L. Davis ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 42 2003 954 970
6. J.N. Cohn, M.A. Pfeffer, J. Rouleau, N. Sharpe, K. Swedberg, and M. Straub MOXCON Investigators. Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON) Eur J Heart Fail 5 2003 659 667 (Pubitemid 38043972)
7. W.S. Colucci, D.B. Sawyer, K. Singh, and C. Communal Adrenergic overload and apoptosis in heart failure: implications for therapy J Card Fail 6 2 Suppl 1 2000 1 7 (Pubitemid 30439432)
8. M.R. Dent, S. Das, and N.S. Dhalla Alterations in both death and survival signals for apoptosis in heart failure due to volume overload J Mol Cell Cardiol 43 2007 726 732 (Pubitemid 350166386)
9. A.O. Doesch, S. Mueller, M. Konstandin, S. Celik, A. Kristen, and L. Frankenstein Effects of protein A immunoadsorption in patients with chronic dilated cardiomyopathy J Clin Apher 25 2010 315 322
10. R. El-Ayoubi, J. Gutkowska, S. Regunathan, and S. Mukaddam-Daher Imidazoline receptors in the heart: characterization, distribution, and regulation J Cardiovasc Pharmacol 39 2002 875 883 (Pubitemid 34538818)
11. 1-receptors and natriuretic peptides by chronic treatment with moxonidine Ann NY Acad Sci 009 2003 274 278 (Pubitemid 38265119)
12. G. Esposito, A. Rapacciuolo, S.V. Naga Prasad, H. Takaoka, S.A. Thomas, and W.J.Z. Koch Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress Circulation 105 2002 85 92 (Pubitemid 34049147)
13. P.W. Fedak, S. Verma, R.D. Weisel, and R.K. Li Cardiac remodeling and failure: from molecules to man, Part I Cardiovasc Pathol 14 2005 1 11 (Pubitemid 40248426)
14. R.S. Foo, K. Mani, and R.N. Kitsis Death begets failure in the heart J Clin Invest 115 2005 565 571 (Pubitemid 40322226)
15. P.L. Giudice, J.P. Gagnol, A. Bellucci, G. Buffone, A. Careddu, and G. Magni Autonomic nervous system activity imbalance in cardiomyopathic hamster J Cardiovasc Pharmacol 36 2000 369 375 (Pubitemid 30660468)
16. M.A. Haxhiu, I. Dreshaj, S.G. Schafer, and P. Ernsberger Selective antihypertensive action of moxonidine is mediated mainly by I1-imidazoline receptors in the rostral ventrolateral medulla J Cardiovasc Pharmacol 24 1994 S1 S8
17. S. Honsho, S. Nishikawa, K. Amano, K. Zen, Y. Adachi, and E. Kishita Pressure-mediated hypertrophy and mechanical stretch induces IL-1 release and subsequent IGF-1 generation to maintain compensative hypertrophy by affecting Akt and JNK pathways Circ Res 105 2009 1149 1158
18. J.J. Kabara, R.M. Riggin, and P.T. Kissinger Abnormal levels of urinary catecholamines in dystrophic mice and hamsters Proc Soc Exp Biol Med 15 1976 168 172
19. T. Kawada, Y. Nakatsuru, A. Sakamoto, T. Koizumi, W.S. Shin, and Y. Okai-Matsuo Strain- and age-dependent loss of sarcoglycan complex in cardiomyopathic hamster hearts and its re-expression by delta-sarcoglycan gene transfer in vivo FEBS Lett 458 1999 405 408 (Pubitemid 29433844)
20. K. Kawai, F. Qin, J. Shite, W. Mao, S. Fukuoka, and C.S. Liang Importance of antioxidant and antiapoptotic effects of beta-receptor blockers in heart failure therapy Am J Physiol Heart Circ Physiol 287 2004 H1003 H1012
21. D.M. Kaye, J. Lefkovits, G.L. Jennings, P. Bergin, A. Broughton, and M.D. Esler Adverse consequences of high sympathetic nervous activity in the failing human heart J Am Coll Cardiol 26 1995 1257 1263
22. T. Kubota, M. Miyagishima, C.S. Frye, S.M. Alber, G.S. Bounoutas, and T. Kadokami Overexpression of tumor necrosis factor-alpha activates both anti- and pro-apoptotic pathways in the myocardium J Mol Cell Cardiol 33 2001 1331 1344 (Pubitemid 32613425)
23. T. Kurum, E. Tatli, and M. Yuksel Effects of carvedilol on plasma levels of pro-inflammatory cytokines in patients with ischemic and nonischemic dilated cardiomyopathy Tex Heart Inst J 34 2007 52 59 (Pubitemid 46588487)
24. A. Leri, Y. Liu, A. Malhotra, Q. Li, P. Stiegler, and P.P. Claudio Pacing-induced heart failure in dogs enhances the expression of p53 and p53-dependent genes in ventricular myocytes Circulation 97 1998 194 203 (Pubitemid 28124678)
25. B. Mayer, S.R. Holmer, C. Hengstenberg, W. Lieb, M. Pfeifer, and H. Schunkert Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels Int J Cardiol 103 2005 182 186 (Pubitemid 41096032)
26. R. Mobini, M. Fu, P.A. Jansson, C.H. Bergh, M. Scharin Täng, and F. Waagstein Influence of central inhibition of sympathetic nervous activity on myocardial metabolism in chronic heart failure: acute effects of the imidazoline I1-receptor agonist moxonidine Clin Sci (Lond) 110 2006 329 336 (Pubitemid 43341635)
27. N. Moorjani, P. Catarino, D. Trabzuni, S. Saleh, A. Moorji, and N. Dzimiri Upregulation of Bcl-2 proteins during the transition to pressure overload-induced heart failure Int J Cardiol 116 2007 27 33 (Pubitemid 46227602)
28. W. Motz, S. Scheler, and B. Mox The potential clinical application of moxonidine in congestive heart failure Rev Contemp Pharmacother 9 1998 473 479 (Pubitemid 28410069)
29. S. Mukaddam-Daher, and J. Gutkowska Atrial natriuretic peptide is involved in the renal actions of moxonidine Hypertension 35 2000 1215 1220 (Pubitemid 30413653)
30. S. Mukaddam-Daher, A. Menaouar, P.-A. Paquette, M. Jankowski, J. Gutkowska, and M.-A. Gillis Hemodynamic and cardiac effects of chronic eprosartan and moxonidine therapy in Stroke Prone Spontaneous Hypertensive Rats Hypertension 53 2009 775 781
31. D.M. Nance, and V.M. Sanders Autonomic innervation and regulation of the immune system (1987-2007) Brain Behav Immun 21 2007 736 745 (Pubitemid 47002215)
32. Oldenburg O, Bitter T, Lehmann R, Korte S, Dimitriadis Z, Faber L, et al. Adaptive servoventilation improves cardiac function and respiratory stability. Clin Res Cardiol Published online 12 Sept. 2010.
33. J.P. Ollivier, and M.O. Christen I1-imidazoline-receptor agonists in the treatment of hypertension: an appraisal of clinical experience J Cardiovasc Pharmacol 24 1994 S39 S48
34. P.A. Paquette, D. Duguay, R. El-Ayoubi, A. Menaouar, B. Danalache, and J. Gutkowska Control of left ventricular mass by moxonidine involves reduced DNA synthesis and enhanced DNA fragmentation Br J Pharmacol 153 2008 459 467 (Pubitemid 351199016)
35. M. Pauschinger, D. Knopf, S. Petschauer, A. Doerner, W. Poller, and P.L. Schwimmbeck Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio Circulation 99 1999 2750 2756 (Pubitemid 29250020)
36. V.V. Petrov, R.H. Fagard, and P.J. Lijnen Stimulation of collagen production by transforming growth factor-beta1 during differentiation of cardiac fibroblasts to myofibroblasts Hypertension 39 2002 258 263 (Pubitemid 34165225)
37. M. Rauchhaus, W. Doehner, D.P. Francis, C. Davos, M. Kemp, and C. Liebenthal Plasma cytokine parameters and mortality in patients with chronic heart failure Circulation 102 2000 3060 3067
38. T. Reffelmann, and R.A. Kloner Trans-thoracic echocardiography in rats. Evaluation of commonly used indices of left ventricular dimensions, contractile performance, and hypertrophy in a genetic model of hypertrophic heart failure (SHHF-Mcc-facp-Rats) in comparison with Wistar rats during aging Basic Res Cardiol 98 2003 275 284 (Pubitemid 37107654)
39. D.A. Siwik, D.L.-F. Chang, and W.S. Colucci Interleukin-1β and tumor necrosis factor-a decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro Circ Res 86 2000 1259 1265 (Pubitemid 30436667)
40. D. Stilli, L. Bocchi, R. Berni, M. Zaniboni, F. Cacciani, and C. Chaponnier Alpha-skeletal actin expression, ventricular fibrosis and heart function correlate with the degree of pressure overload cardiac hypertrophy Exp Physiol 91 2006 571 580
41. K. Swedberg, M.R. Bristow, J.N. Cohn, H. Dargie, M. Straub, and C. Wiltse Moxonidine Safety and Efficacy (MOXSE) Investigators. Effects of sustained-release moxonidine, an imidazoline agonist, on plasma norepinephrine in patients with chronic heart failure Circulation 105 2002 1797 1803 (Pubitemid 34408889)
42. P. Timonen, J. Magga, J. Risteli, K. Punnonen, E. Vanninen, and A. Turpeinen Cytokines, interstitial collagen and ventricular remodelling in dilated cardiomyopathy Int J Cardiol 124 2008 293 300 (Pubitemid 351305377)
43. R. Van Kerckhoven, T.A. van Veen, F. Boomsma, P.R. Saxena, and R.G. Schoemaker Chronic administration of moxonidine suppresses sympathetic activation in a rat heart failure model Eur J Pharmacol 397 2000 113 120 (Pubitemid 30323817)
44. T. Yokoyama, L. Vaca, R.D. Rossen, W. Durante, P. Hazarika, and D.L. Mann Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart J Clin Invest 92 1993 2303 2312 (Pubitemid 23333536)
45. J. Zhang, and A.A. Abdel-Rahman Inhibition of nischarin expression attenuates rilmenidine-evoked hypotension and phosphorylated extracellular signal-regulated kinase1/2 production in the rostral ventrolateral medulla of rats J Pharmacol Exp Ther 324 2008 72 78 (Pubitemid 350294147)